ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 142,42
0,83%
Dow Jones
38 884,26
0,00%
DAX
18 493,56
0,30%
Brent Oil
82,075
-0,95%
Bitcoin
62 234,89
-0,16%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Werewolf Therapeutics Inc (HOWL)

  7. Werewolf Therapeutics Inc (HOWL) Actualités

HOWL Werewolf Therapeutics Inc

5,72
0,00 (0,00%)
Avant marché
Dernière mise à jour : 13:00:10
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Werewolf Therapeutics Inc HOWL NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 5,72 13:00:10
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
5,72
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
03/5/202413:00GLOBEWerewolf Therapeutics Reports First Quarter 2024 Financial..
24/4/202416:05GLOBEWerewolf Therapeutics Announces WTX-124 Clinical Abstract..
23/4/202414:00GLOBEWerewolf Therapeutics Presents First Preclinical Data..
05/4/202422:30GLOBEWerewolf Therapeutics Presents Preclinical Results..
04/4/202422:30GLOBEWerewolf Therapeutics to Present First-of-Its-Kind Data..
07/3/202413:22EDGAR2Form S-8 - Securities to be offered to employees in employee..
07/3/202413:15EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
07/3/202413:11EDGAR2Form 8-K - Current report
07/3/202413:00GLOBEWerewolf Therapeutics Reports Fourth Quarter and Full Year..
06/3/202414:00GLOBEWerewolf Therapeutics to Present at the 2024 Leerink..
05/3/202422:30GLOBEWerewolf Therapeutics Announces Upcoming Presentations at..
09/2/202422:39EDGAR2Form 8-K - Current report
09/2/202422:35EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
08/1/202414:08EDGAR2Form 8-K - Current report
05/1/202401:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202401:13EDGAR2Form 3 - Initial statement of beneficial ownership of..
04/1/202423:00EDGAR2Form 8-K - Current report
04/1/202422:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202422:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202422:05GLOBEWerewolf Therapeutics Appoints Michael Atkins, M.D., to its..
22/11/202313:00GLOBEWerewolf Therapeutics to Present at the Evercore ISI..
14/11/202322:34EDGAR2Form 8-K - Current report
14/11/202322:25GLOBEWerewolf Therapeutics Reports Third Quarter 2023 Financial..
03/11/202312:05EDGAR2Form 8-K - Current report
03/11/202312:00GLOBEWerewolf Therapeutics Presents Preliminary Monotherapy Data..
31/10/202314:00GLOBEWerewolf Therapeutics to Present Clinical and Preclinical..
27/9/202315:00GLOBEWerewolf Therapeutics Announces Upcoming Presentations at..
18/9/202313:00EDGAR2Form 8-K - Current report
11/9/202322:05GLOBEWerewolf Therapeutics to Host KOL Event Highlighting IL-2..
05/9/202322:05GLOBEWerewolf Therapeutics to Participate in Upcoming Investor..
24/8/202320:00APSBiotech Soars On New Price Target And Analyst Rating
10/8/202313:16EDGAR2Form 8-K - Current report
10/8/202313:10GLOBEWerewolf Therapeutics Reports Second Quarter 2023 Financial..
10/8/202313:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/6/202313:00GLOBEWerewolf Therapeutics to Present at the Jefferies Healthcare..
11/5/202313:00GLOBEWerewolf Therapeutics Reports First Quarter 2023 Financial..

Dernières Valeurs Consultées

NASDAQ
HOWL
Werewolf Therapeutics
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés